新闻/Reuters/ProQR Announces CTA Submission For Phase 1 Study Of AX-0810 Targeting NTCPProQR Announces CTA Submission For Phase 1 Study Of AX-0810 Targeting NTCPRefinitiv阅读少于1分钟PRQRProQR Therapeutics NV PRQR:PROQR ANNOUNCES CTA SUBMISSION FOR PHASE 1 STUDY OF AX-0810 TARGETING NTCPReuters欧洲美国股票荷兰股票© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html显示更多登录或创建永久免费帐户以阅读此新闻我们开始吧
